CLIMB BIO INC(CLYM)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CLYM CLIMB BIO INC

休市中 04-04 16:00:00 EDT

1.17

+0.02

+1.74%

盘后1.17

+0.000.00%

19:29 EDT

最高1.20	最低1.09	成交量56.54万
今开1.12	昨收1.15	日振幅9.57%
总市值7,895万	流通市值3,585万	总股本6,748万
成交额63.28万	换手率1.85%	流通股本3,064万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"CLYM","market":"US","secType":"STK","nameCN":"CLIMB BIO INC","latestPrice":1.17,"timestamp":1743796800000,"preClose":1.15,"halted":0,"volume":565406,"hourTrading":{"tag":"盘后","latestPrice":1.17,"preClose":1.17,"latestTime":"19:29 EDT","volume":1577,"amount":1847.7304,"timestamp":1743809346292},"delay":0,"floatShares":30642992,"shares":67475395,"eps":-1.5343,"marketStatus":"休市中","change":0.02,"latestTime":"04-04 16:00:00 EDT","open":1.12,"high":1.2,"low":1.09,"amount":632773.9552782,"amplitude":0.095652,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.5343,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1744012800000},"marketStatusCode":7,"adr":0,"listingDate":1628222400000,"exchange":"NASDAQ","adjPreClose":1.15,"preHourTrading":{"tag":"盘前","latestPrice":1.15,"preClose":1.15,"latestTime":"08:09 EDT","volume":10,"amount":11.5,"timestamp":1743768567003},"postHourTrading":{"tag":"盘后","latestPrice":1.17,"preClose":1.17,"latestTime":"19:29 EDT","volume":1577,"amount":1847.7304,"timestamp":1743809346292},"volumeRatio":3.678959234138317},"requestUrl":"/m/hq/s/CLYM/wiki","defaultTab":"wiki","newsList":[{"id":"2484991306","title":"Climb Bio, Inc.2024财年第三财季实现净利润-8.90百万美元，同比减少124.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484991306","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2484991306?lang=zh_cn&edition=full","pubTime":"2024-11-19 18:00","pubTimestamp":1732010429,"startTime":"0","endTime":"0","summary":"11月19日，Climb Bio, Inc.公布财报，公告显示公司2024财年第三财季净利润为-8.90百万美元，同比减少124.18%；其中营业收入为0.00美元，每股基本收益为-0.13美元。从资产负债表来看，Climb Bio, Inc.总负债3.42百万美元，其中短期债务58000.00美元，资产负债比为0.65，流动比率为0.58。机构评级：截至2024年11月19日，当前有2家机构对Climb Bio, Inc.目标价做出预测，其中目标均价为4.50美元，其中最低目标价为4.00美元，最高目标价为5.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119180146a24562b4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119180146a24562b4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLYM"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.eliemtx.com","stockEarnings":[{"period":"1week","weight":-0.0859},{"period":"1month","weight":-0.1702},{"period":"3month","weight":-0.48},{"period":"6month","weight":-0.7733},{"period":"1year","weight":-0.5806},{"period":"ytd","weight":-0.35}],"compareEarnings":[{"period":"1week","weight":-0.0907},{"period":"1month","weight":-0.1334},{"period":"3month","weight":-0.1464},{"period":"6month","weight":-0.1182},{"period":"1year","weight":-0.0152},{"period":"ytd","weight":-0.1379}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Climb Bio, Inc.于2018年10月18日作为特拉华州公司注册成立。该公司是一家生物技术公司，专注于开发神经元兴奋性障碍的新疗法，以解决精神病学、癫痫、慢性疼痛以及外周和中枢神经系统疾病方面未满足的需求。","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.044593},{"month":2,"riseRate":0.5,"avgChangeRate":-0.039153},{"month":3,"riseRate":0.25,"avgChangeRate":-0.102291},{"month":4,"riseRate":0.5,"avgChangeRate":0.251501},{"month":5,"riseRate":0.666667,"avgChangeRate":0.076469},{"month":6,"riseRate":0,"avgChangeRate":-0.110135},{"month":7,"riseRate":0.666667,"avgChangeRate":0.058695},{"month":8,"riseRate":0,"avgChangeRate":-0.068582},{"month":9,"riseRate":0.25,"avgChangeRate":-0.130981},{"month":10,"riseRate":0.25,"avgChangeRate":-0.066822},{"month":11,"riseRate":0,"avgChangeRate":-0.143309},{"month":12,"riseRate":0.5,"avgChangeRate":-0.056887}],"exchange":"NASDAQ","name":"CLIMB BIO INC","nameEN":"CLIMB BIO INC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.32.1","shortVersion":"4.32.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"CLIMB BIO INC(CLYM)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供CLIMB BIO INC(CLYM)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"CLIMB BIO INC,CLYM,CLIMB BIO INC股票,CLIMB BIO INC股票老虎,CLIMB BIO INC股票老虎国际,CLIMB BIO INC行情,CLIMB BIO INC股票行情,CLIMB BIO INC股价,CLIMB BIO INC股市,CLIMB BIO INC股票价格,CLIMB BIO INC股票交易,CLIMB BIO INC股票购买,CLIMB BIO INC股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"CLIMB BIO INC(CLYM)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供CLIMB BIO INC(CLYM)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}